U.S. markets open in 7 hours 15 minutes
  • S&P Futures

    4,377.25
    -34.50 (-0.78%)
     
  • Dow Futures

    34,860.00
    -114.00 (-0.33%)
     
  • Nasdaq Futures

    14,844.50
    -193.25 (-1.29%)
     
  • Russell 2000 Futures

    2,221.00
    -16.50 (-0.74%)
     
  • Crude Oil

    73.08
    -0.54 (-0.73%)
     
  • Gold

    1,832.10
    -3.70 (-0.20%)
     
  • Silver

    25.60
    -0.18 (-0.69%)
     
  • EUR/USD

    1.1885
    -0.0011 (-0.10%)
     
  • 10-Yr Bond

    1.2690
    0.0000 (0.00%)
     
  • Vix

    17.70
    -0.61 (-3.33%)
     
  • GBP/USD

    1.3943
    -0.0015 (-0.11%)
     
  • USD/JPY

    109.5650
    +0.1040 (+0.10%)
     
  • BTC-USD

    39,669.32
    -482.27 (-1.20%)
     
  • CMC Crypto 200

    943.07
    +12.71 (+1.37%)
     
  • FTSE 100

    7,078.42
    +61.79 (+0.88%)
     
  • Nikkei 225

    27,295.66
    -486.76 (-1.75%)
     

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Immunovant, Inc. (IMVT) and Encourages Stockholders to Contact the Firm

·1 min read

PHILADELPHIA, PA / ACCESSWIRE / June 2, 2021 / Kaskela Law LLC announces that it is investigating Immunovant, Inc. (Nasdaq: IMVT) on behalf of the Company's stockholders.

On June 1, 2021, shares of Immunovant's common stock declined $5.76 per share, or 38% in value, after the Company reported its financial and operational results for the Quarter and Fiscal Year ended March 31, 2021, and disclosed that its Chief Medical Officer ("CMO"), Rita Jain, M.D., had stepped down "to pursue another opportunity."

The investigation seeks to determine whether Immunovant and the company's executive officers and/or directors violated the securities laws in connection with statements made to investors, and whether Immunovant investors have been harmed as a result of such actions.

Immunovant investors are encouraged to contact Kaskela Law LLC at https://kaskelalaw.com/case/immunovant-inc/ for additional information about this investigation and their legal rights and options.

Kaskela Law LLC represents investors in securities fraud, corporate governance, and merger & acquisition litigation. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com. This notice may constitute attorney advertising in certain jurisdictions.

CONTACT:

D. Seamus Kaskela, Esq.
KASKELA LAW LLC
18 Campus Boulevard, Suite 100
Newtown Square, PA 19073
(484) 258 - 1585
www.kaskelalaw.com
skaskela@kaskelalaw.com

SOURCE: Kaskela Law LLC



View source version on accesswire.com:
https://www.accesswire.com/650097/SHAREHOLDER-ALERT-Kaskela-Law-LLC-Announces-Investigation-of-Immunovant-Inc-IMVT-and-Encourages-Stockholders-to-Contact-the-Firm